Clinical Trial: Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension
Study Status: Completed
Recruit Status: RECRUITING
Condition: Depressive Disorder
Study Type: INTERVENTIONAL
Official Title: Open Label Extension Study of Depressed Mood Improvement Through Nicotine (Depressed MIND3)
Brief Summary:
Deficits in cognitive control are core features of late-life depression (LLD), contributing both to emotion dysregulation and problems with inhibiting irrelevant information, conflict detection, and working memory.Clinically characterized as executive dysfunction, these deficits are associated with poor response to antidepressants and higher levels of disability.Improvement of cognitive control network (CCN) dysfunction may benefit both mood and cognitive performance, however no current pharmacotherapy improves…
Read more